Haptoglobulin PFH457
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: Next day (11:00)
Hazelnut PFH458
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Hb Electrophoresis by HPLC PFH459
Includes:
Sample: WB-EDTA (3ml)
Methodology: HPLC
Reporting: Next day (11:00)
HCV - IgM Antibody PFH460
Includes:
Sample: Serum (1 ml)
Methodology: ELISA
Reporting: Next day (11:00)
HCV RNA Viral Load & HCV Genotyping PFH461
Includes:
Sample: WB-EDTA - Plasma (3 mL)
Methodology: *RIT
Reporting: 1 (11:00)
Helicobacter Pylori IgA PFH462
Includes:
Sample: Serum (1ml)
Methodology: EIA
Reporting: 5 (19:00)
Helicobacter Pylorii IgG PFH463
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 2 & 4 & 1 (11:00)
Helicobacter Pylorii IgM PFH464
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 2 & 4 & 1 (11:00)
Hematuria PFH465
Includes:
Sample: Urine (5 ml)
Methodology: Microscopy
Reporting: 11:00/19:00
Hemoglobin (HB) PFH466
Includes:
Sample: WB-EDTA (3ml)
Methodology: Cell Counter
Reporting: 11:00/19:00
Hepatitis A virus - (HAV IgG) PFH467
Includes:
Sample: Serum (1ml)
Methodology: Competitive ELISA
Reporting: 11:00/18:00
Hepatitis A virus - IgM (HAV- IgM) PFH468
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Hepatitis B envelope Antibody (AntiHBe) PFH469
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Hepatitis B Envelope Antigen (HBeAg) PFH470
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Hepatitis B surface Antibody Total (Anti HBs) PFH471
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Hepatitis B Surface antigen (HBsAg) PFH472
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Hepatitis B Surface antigen (HBsAg)-Rapid PFH473
Includes:
Sample: Serum (1ml)
Methodology: Rapid
Reporting: 11:00/18:00
Hepatitis B Virus - Genotyping PFH474
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Real Time PCR
Reporting: 5 (11:00)
Hepatitis B Virus - Viral Load PFH475
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Real Time PCR
Reporting: 2 & 4 & 6 (11:00)
Hepatitis B Virus, Qualitative PFH476
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Real Time PCR
Reporting: 2 & 4 & 6 (11:00)
Hepatitis C Virus - Genotyping PFH477
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Real Time PCR
Reporting: 1 (11:00)
Hepatitis C Virus - Qualitative PFH478
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Real Time PCR
Reporting: 3 & 5 & 1 (11:00)
Hepatitis C Virus - Viral Load PFH479
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Real Time PCR
Reporting: 3 & 5 & 1 (11:00)
Hepatitis C Virus (HCV Antibody) PFH480
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Hepatitis C Virus (HCV Antibody)-Rapid PFH481
Includes:
Sample: Serum (1ml)
Methodology: Rapid
Reporting: 11:00/18:00
Hepatitis C Virus (IgG) PFH482
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Hepatitis Core Antibody IgM (Anti HBc - IgM) PFH483
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Hepatitis Core Antibody Total (HBcAb- Total) PFH484
Includes:
Sample: Serum (1ml)
Methodology: Competitive ELISA
Reporting: 11:00/18:00
Hepatitis E virus - IgG (HEV IgG) PFH485
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Hepatitis E virus - IgM (HEV IgM) PFH486
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Herpes Simplex Virus 1 & 2 IgG PFH487
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Herpes Simplex Virus 1 & 2 IgM PFH488
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Herpes Simplex Virus 1 IgG PFH489
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Herpes Simplex Virus 1 IgM PFH490
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Herpes Simplex Virus 2 IgG PFH491
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Herpes Simplex Virus 2 IgM PFH492
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
Herpes Simplex Virus DNA PCR - Qualitative PFH493
Includes:
Sample: WB-EDTA (3ml) / CSF (1mL)
Methodology: Real Time PCR
Reporting: 2 & 4 & 6 (11:00)
High Sensitive CRP (hsCRP) PFH494
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: 11:00/19:00
HIV - Quantitative (Viral Load) PFH495
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Real Time PCR
Reporting: 3 & 5 & 1 (11:00)
HIV 1 & 2 Antibody PFH496
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 11:00/18:00
HIV 1 & 2 Antibody -Rapid PFH497
Includes:
Sample: Serum (1ml)
Methodology: Rapid
Reporting: 11:00/18:00
HIV 1 AND 2 AND P24 COMBO PFH498
Includes:
Sample: Serum (1 ml)
Methodology: CLIA
Reporting: 4 Days (11:00)
HIV 1 Western Blot PFH499
Includes:
Sample: Serum (1ml)
Methodology: Western Blot
Reporting: Next day (11:00)
HIV-DNA PCR - Qualitative PFH500
Includes:
Sample: WB-EDTA (3ml)
Methodology: Real Time PCR
Reporting: 2 & 4 & 6 (11:00)
HIV-I Drug Resistance Assay (PI) PFH501
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Phenotyping
Reporting: 15 th Day (11:00)
HIV-I Drug Resistance Assay (RT) PFH502
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Phenotyping
Reporting: 15 th Day (11:00)
HIV-RNA PCR - Qualitative PFH503
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: Real Time PCR
Reporting: 3 & 5 & 1 (11:00)
HLA - A,B,C,DR Typing PFH504
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA - BONE MARROW TRANSPLANT A,B,C DR & DQ TYPING PFH505
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA- (CLASS II ) TYPING PFH506
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA -A,B,C DRB1,DQBI PFH507
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA B- 27 PCR PFH508
Includes:
Sample: WB-EDTA (3 ml)
Methodology: Real Time PCR
Reporting: 2 & 4 & 6 (11:00)
HLA B-27 PFH509
Includes:
Sample: WB-EDTA (3ml)
Methodology: Flow Cytometry
Reporting: 11:00/19:00
HLA CELIAC DISEASE (DQB1*02, 1*03, DQA1*05;01) PFH510
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA DR (Activation Marker) PFH511
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
HLA- KIDNEY TRANSPLANT A,B& DR TYPING PFH512
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA PANEL REACTIVE ANTIBODIES PFH513
Includes:
Sample: 3 ml serum from SST tube
Methodology: Complement Dependant Cytotoxicity
Reporting: 4 (19:00)
HLA- T AND B CELL LYMPHOCYTE CROSS MATCH PFH514
Includes:
Sample: RECIEPENT-20 mL (10 mL min.) whole blood in 2 Yellow Top (ACD) tubes AND 3 mL (2 mL min.) serum from 1 SST. DONOR: 20 mL (10 mL min.) whole blood in 2 Yellow Top (ACD) tubes. Ship refrigerated. (Donor+Recipient)
Methodology: Complement Dependent Cytotoxicity with DTT treatment
Reporting: Next Day (19:00)
HLA-A B DRB1/3/4/5 TYPE KIT PFH515
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA-A TYPING PFH516
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA-A,B,C TYPING PFH517
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA-B TYPING PFH518
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA-C TYPING PFH519
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA-DQ Typing PFH520
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA-DR Typing PFH521
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
HLA-DRB1/3/4/5 TYP KIT PFH522
Includes:
Sample: Peripheral Blood - EDTA (3 ml)
Methodology: SSOP
Reporting: 3 & 6 (19:00)
Homocysteine PFH523
Includes:
Sample: WB-EDTA (1ml)/Plasma (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Horse Dander PFH524
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Housedust PFH525
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
HTLV 1 + 2 Antibody PFH526
Includes:
Sample: Serum (1 ml)
Methodology: ELISA
Reporting: Next Day (11:00)
Human Papilloma Virus (HPV) ? Quantitative PFH527
Includes:
Sample: Genitourinary Tract Secretion Swab & Tissue biopsy
Methodology: Real Time PCR
Reporting: 2 & 4 & 6 (11:00)
